If you want to travel next year, you may need a vaccine passport

Various companies and technology groups began to develop applications or systems for smartphones for individuals to upload details of their Covid-19 tests and vaccines, creating digital credentials that can be shown to enter concert venues, stadiums, cinemas, offices or even countries.

The Common Trust Network, an initiative by the non-profit organization The Commons Project and the World Economic Forum, has partnered with several airlines, including Cathay Pacific, JetBlue, Lufthansa, Swiss Airlines, United Airlines and Virgin Atlantic, as well as hundreds of systems in the United States and the Aruba government.
The CommonPass app created by the group allows users to upload medical data, such as a Covid-19 test result or, eventually, proof of vaccination by a hospital or medical professional, generate a health certificate or pass it in the form of a QR code that can be shown to the authorities without revealing confidential information. For travel, the app lists the health pass requirements at the departure and arrival points based on your itinerary.
“You can be tested every time you cross a border. You cannot be vaccinated every time you cross a border,” said Thomas Crampton, director of marketing and communications for The Commons Project, to CNN Business. He emphasized the need for a set of simple and easily transferable credentials, or “digital yellow card”, referring to the paper document usually issued as proof of vaccination.
Big tech companies are also taking action. IBM (IBM) has developed its own application, called Digital Health Pass, which allows companies and locations to customize indicators they need to enter, including coronavirus tests, temperature checks and vaccination records. The credentials corresponding to these indicators are stored in a mobile wallet.
The IBM Digital Health Pass app creates an online vaccine credential that can be stored in a mobile wallet.

In an effort to address a challenge around returning to normal after vaccines are widely distributed, developers may now have to face other challenges, ranging from privacy issues to representing the varying effectiveness of different vaccines. But the most urgent challenge may be simply to avoid the disjointed implementation and mixed success of the technology’s previous attempt to deal with the public health crisis: contact tracking applications.

At the beginning of the pandemic, Apple (AAPL) and Google (GOOG) put smartphone rivalry aside to jointly develop a Bluetooth-based system to notify users if they have been exposed to someone with Covid-19. Many countries and state governments around the world have also developed and used their own applications.
“I think where exposure reporting encountered some challenges was more in fragmented implementation choices, lack of federal leadership … where each state had to act alone and so each state had to find this out independently,” said Jenny Wanger , which leads exposure notification initiatives for the Linux Foundation Public Health, a technology-focused organization that helps public health officials around the world fight Covid-19.
To encourage better coordination this time, the Linux Foundation partnered with the Covid-19 Credentials Initiative, a collective of more than 300 people representing dozens of organizations on five continents and is also working with IBM and CommonPass to help develop a set of universal standards for vaccine credential applications.

“If we are successful, you should be able to say: I have a vaccine certificate on my phone that I received when I was vaccinated in a country, with a whole set of health management practices … that I use to I took a plane to a totally different country and then presented in that new country a vaccination credential so that I could go to that show that was happening at home, whose participation was limited to those who demonstrated that they had taken the vaccine “. Said Brian Behlendorf, director executive of the Linux Foundation.

“It must be interoperable in the same way that email is interoperable, in the same way that the web is interoperable, “he said.” We are currently in a situation where there are some moving parts that bring us closer to this, but I think there is a sincere commitment from everyone in the industry. ”

Part of ensuring the wide use of vaccine passports is responsible for the large subset of the global population that does not yet use or have access to smartphones. Some companies within the Covid-19 Credentials Initiative are also developing a smart card that strikes a compromise between traditional paper vaccine certificates and an online version that is easier to store and reproduce.

“For us it is [about] how this digital credential can be stored, it can be presented, not only through smartphones, but also in other ways for those people who do not have stable internet access and who do not have smartphones, “said Lucy Yang, co-leader of Covid-19 Credentials Initiative. “We are investigating and there are companies that are doing really promising work.

CommonPass has partnered with several airlines to begin deploying their health credential application on select international flights.

After creating a passport for the vaccine, companies will need to make sure that people feel comfortable using it. This means facing concerns about the handling of private medical information.

CommonPass, IBM and Linux Foundation have emphasized privacy as central to their initiatives. IBM says it allows users to control and consent to the use of their health data and allows them to choose the level of detail they want to provide to authorities.

“Trust and transparency remain paramount when developing a platform such as a digital health passport or any solution that addresses confidential personal information,” the company said in a blog. “Putting privacy first is an important priority for managing and analyzing data in response to these complex times.”

With vaccines manufactured by several companies in various countries at various stages of development, there are many variables that passport manufacturers should consider.

“An entry point – be it a border, be it a location – is going to want to know if you got the Pfizer vaccine, you got the Russian vaccine, you got the Chinese vaccine, so they can make a decision accordingly,” said Crampton. The variation can be great: the vaccine developed by the Chinese state pharmaceutical giant Sinopharm, for example, is 86% effective against Covid-19, while the Pfizer and Moderna vaccines are around 95% effective each.

It is also unclear how effective vaccines are at stopping transmission of the virus, says Dr. Julie Parsonnet, an infectious disease specialist at Stanford University. Therefore, although a vaccine passport application shows that you have received the injection, it may not be a guarantee that you will participate in an event or board a flight safely.

“We still don’t know whether vaccinated people can transmit the infection or not,” she told CNN Business. “Until this is cleared up, we will not know whether ‘passports’ will be effective.”

Still, Behlendorf predicts that the launch and adoption of vaccine passports will happen quickly, once everything fits together, and expects a variety of applications that can work with each other to be “widely available” in the first half of 2021.

“Rest assured, the nerds are working on it,” he said.

.Source